Abstract:Mycotic keratitis is common in warm, humid regions with a varying profile of pathogenic fungi according to geographical origin, socioeconomic status, and climatic condition. Clinical diagnosis can be challenging in difficult cases and those refractory to treatment. Fungal hyphae on microscopic examination and culture isolation have been the gold standard in the laboratory diagnosis of fungal keratitis. A culture isolate of the aetiological fungus is essential to perform antifungal susceptibility testing. As the culture isolation of fungi is time-consuming, causing delays in the initiation of treatment, newer investigative modalities such as in vivo confocal microscopy and molecular diagnostic methods have recently gained popularity. Molecular diagnostic techniques now help to obtain a rapid diagnosis of fungal keratitis. Genomic approaches are based on detecting amplicons of ribosomal RNA genes, with internal transcribed spacers being increasingly adopted. Metagenomic deep sequencing allows for rapid and accurate diagnosis without the need to wait for the fungus to grow. This is also helpful in identifying new emerging strains of fungi causing mycotic keratitis. A custom-tear proteomic approach will probably play an important diagnostic role in future in the management of mycotic keratitis. Positive repeat cultures are being suggested as an important gauge indicative of a poor prognosis. Positive repeat fungal cultures help to modify a treatment regimen by increasing its frequency, providing the addition of another topical and oral antifungal agent along with close follow-up for perforation and identifying need for early therapeutic keratoplasty. The role of collagen crosslinking in the treatment of fungal keratitis is not convincingly established. Rapid detection by multiplex PCR and antifungal susceptibility testing of the pathogenic fungi, adopted into a routine management protocol of fungal keratitis, will help to improve treatment outcome. Early therapy is essential in minimizing damage to the corneal tissue, thereby providing a better outcome. The role of conventional therapy with polyenes, systemic and targeted therapy of antifungal agents, newer azoles and echinocandins in fungal keratitis has been widely studied in recent times. Combination therapy can be more efficacious in comparison to monotherapy. Given the diversity of fungal aetiology, the emergence of new corneal pathogenic fungi with varying drug susceptibilities, increasing the drug resistance to antifungal agents in some genera and species, it is perhaps time to adopt recent molecular methods for precise identification and incorporate antifungal susceptibility testing as a routine.

Pseudopithomyces Maydicus and Phialophora Chinensis Rare Fungal Keratitis: Case Series, DNA Sequencing, Antifungal Susceptibility Patterns

Case Report: A Rare Fungal Keratitis Caused by <i>Plectosphaerella Cucumerina</i>

Pseudonectria keratitis—emerging pathogenic fungi in the eye

Infectious Keratitis Caused by Rare and Emerging Micro-Organisms

A rare case of keratitis due to co-infection with Plectosphaerella cucumerina and Acanthamoeba T5 genotype

S1.5d Spectrum of etiological agents of mycotic keratitis: A n 11- year review

Colletotrichum keratitis: A rare yet important fungal infection of human eyes

Botryosphaeria dothidea Mycotic Keratitis: A Novel Phytopathogen Causing Human Infection

EPIDEMIOLOGICAL INVESTIGATION OF PATHOGENIC FUNGUS IN FUNGAL KERATITIS

Fungal spectrum identified by a new slide culture and in vitro drug susceptibility using Etest in fungal keratitis.

Breaking new ground: First case of keratitis by Apiospora

Successful Management of Pythium insidiosum Keratitis Masquerading as Dematiaceous Fungal Keratitis in an Immunosuppressed Asian Male

Purpureocillium roseum sp. nov. A new ocular pathogen for humans and mice resistant to antifungals

P289 A teenage with Pythium keratitis—a case report

Fungal Keratitis: Epidemiology, Rapid Detection, and Antifungal Susceptibilities of Fusarium and Aspergillus Isolates from Corneal Scrapings

Recent Perspectives in the Management of Fungal Keratitis

Fusarium Keratitis From a Comprehensive Eye Health Care Facility in South India: Molecular Characterization by MALDI-TOF Versus Polymerase Chain Reaction Sequencing, Species Complex Distribution, and Clinical Correlation

Current Perspectives on Ophthalmic Mycoses

Fungal keratitis caused by Coniochaeta mutabilis-A case report

Severe fusarium oxysporum keratomycosis: About 2 Cases

In Vivo Confocal Microscopy Findings of a Rare Cryptococcus neoformans Keratitis